These Health Research Funders Are Facing Down the Next Pandemic Threat — Whatever It May Be

These Health Research Funders Are Facing Down the Next Pandemic Threat — Whatever It May Be

The Gates Foundation, Novo Nordisk Foundation and Open Philanthropy are collaborating under a partnership called Pandemic Antiviral Discovery, funding research to develop treatments that may be needed for future pandemics.

Read More

A Q&A With Stanley Druckenmiller on Priorities, Big Bets and Feeling "Incredibly Privileged"

A Q&A With Stanley Druckenmiller on Priorities, Big Bets and Feeling "Incredibly Privileged"

In this candid conversation, the storied investor and mega-donor discusses what he and his wife Fiona look for in grantees, how much they plan to give away, why they won’t sign the Giving Pledge, and more.

Read More

Six Things to Know About This Billionaire Hedge Fund Manager’s Philanthropy

Six Things to Know About This Billionaire Hedge Fund Manager’s Philanthropy

Stanley and Fiona Druckenmiller have a $1.9 billion foundation and a reported fortune of $10 billion. Here’s a closer look at how the couple makes big bets for economic mobility, the environment and health.

Read More

COVID Won't be the Last Pandemic. A Top Biomedical Funder Seeks to Get Ahead of Emerging Pathogens

COVID Won't be the Last Pandemic. A Top Biomedical Funder Seeks to Get Ahead of Emerging Pathogens

With a $100 million commitment, the Howard Hughes Medical Institute is the latest funder backing research to prepare for pathogens with the potential to threaten human health, or even trigger new pandemics. 

Read More

This Wealthy Virginia Family Is Helping Make the State a Biotech Hub

This Wealthy Virginia Family Is Helping Make the State a Biotech Hub

Paul and Diane Manning, longtime supporters of diabetes research at the University of Virginia, recently committed $100 million to build an advanced biotech research institute there. Here’s a rundown on the gift and the donors.

Read More

Sergey Brin's Off-the-Radar Foundation Is Huge — and Growing Fast. Here’s What We Know About It

Sergey Brin's Off-the-Radar Foundation Is Huge — and Growing Fast. Here’s What We Know About It

Sergey Brin’s foundation has nearly $5 billion in assets and a portfolio spanning Parkinson’s disease, science and activism. It’s not known for transparency, but we do know a fair amount about what it supports and why.

Read More

What We Learned From a Deep Dive Into Cancer Research Giving

What We Learned From a Deep Dive Into Cancer Research Giving

As part of IP’s State of American Philanthropy project, we recently published an in-depth paper on trends in cancer research funding. Author Mike Scutari overviews what we learned and offers clues on what to expect going forward.

Read More

A Funding Leader Lays Out Key Priorities in Neuromuscular Disease Research

A Funding Leader Lays Out Key Priorities in Neuromuscular Disease Research

The Chicago-based Muscular Dystrophy Association is a leading funder in the field of neuromuscular diseases. We check in with Chief Research Officer Dr. Sharon Hesterlee to discuss current challenges and priorities.

Read More

“A Period of Rapid Change.” How the ALS Association Shepherded a New Treatment to Market

“A Period of Rapid Change.” How the ALS Association Shepherded a New Treatment to Market

The FDA recently approved a new drug to treat ALS. Here’s how the ALS Association, equipped with funding from 2014’s viral Ice Bucket Challenge, contributed to that outcome — and what it’s looking to do next.

Read More

A New Alliance Channels Asia's Growing Philanthropic Heft

A New Alliance Channels Asia's Growing Philanthropic Heft

Top grantmakers from Asia and the U.S. have joined forces on a new Philanthropy Asia Alliance, and are already backing six on-the-ground projects. The alliance highlights Singapore’s role as a hub for Asian philanthropy.

Read More

A New Koch in Town: Four Things to Note About the Philanthropy of America's Richest Woman

A New Koch in Town: Four Things to Note About the Philanthropy of America's Richest Woman

Since her husband David Koch’s passing in 2019, Julia Koch has kept a fairly low philanthropic profile. But the sheer scale of her fortune means much larger giving may be coming down the line. Here are a few things to look out for.

Read More

The Bezos Family Committed $710 Million to Disease Research. Here’s How That Came Together

The Bezos Family Committed $710 Million to Disease Research. Here’s How That Came Together

The Bezos family’s mega-commitment to the Fred Hutchinson Cancer Center will fund cancer and infectious disease research. The gift has a 20-year backstory, and offers a peek at how the fantastically wealthy clan operates.

Read More

Taking on Paralysis, the Christopher & Dana Reeve Foundation Seeks to "Care and Cure"

Taking on Paralysis, the Christopher & Dana Reeve Foundation Seeks to "Care and Cure"

Once viewed as the “graveyard of neuroscience,” the field of spinal cord injury has made headway thanks to the Christopher & Dana Reeve Foundation. We check in with two leaders to discuss challenges and opportunities.

Read More

Philanthropy Made a Flurry of Commitments During the UN Meeting. Here’s Where the Money is Headed

Philanthropy Made a Flurry of Commitments During the UN Meeting. Here’s Where the Money is Headed

Philanthropy was more active than usual in last week’s United Nations General Assembly, as the secretary general called for a “rescue mission” to get Sustainable Development Goals on track. Here’s a rundown of the big pledges.

Read More

Bloomberg Weighs in on Philanthropy’s Role in SDGs, Fighting Noncommunicable Diseases

Bloomberg Weighs in on Philanthropy’s Role in SDGs, Fighting Noncommunicable Diseases

Michael Bloomberg just received his third reappointment as global ambassador for noncommunicable diseases and injuries. The mega-donor shared some insights with IP on how donors can impact global health and more.

Read More

Parkinson's Funders Take a Venture Philanthropy Approach to Speed Development of Treatments

Parkinson's Funders Take a Venture Philanthropy Approach to Speed Development of Treatments

The Parkinson's Foundation in the U.S. and Parkinson's U.K. have inked a new partnership to boost investment in treatments for the neurodegenerative condition that affects 10 million people worldwide.

Read More

New Funding Aims to Accelerate Treatments for Lupus, an Autoimmune Disease with Many Faces

New Funding Aims to Accelerate Treatments for Lupus, an Autoimmune Disease with Many Faces

Often missed or misdiagnosed, lupus disproportionately affects women of color in the U.S. Here’s how a leading lupus research funder is speeding along the development of much-needed treatments.

Read More

Informed By COVID, a Coalition of Funders Backs Community Health Workers in Africa

Informed By COVID, a Coalition of Funders Backs Community Health Workers in Africa

The Africa Frontline First Catalytic Fund is setting its sights on compensating and training community health workers, who play a crucial role in addressing public health problems. Two major foundations have already signed on.

Read More

When It Comes to Philanthropic Funding for Research, Not All Cancers Are Created Equal

When It Comes to Philanthropic Funding for Research, Not All Cancers Are Created Equal

A team of researchers discovered that work on some of the most lethal types of cancer is consistently underfunded. We dig into their findings with co-author Suneel Kamath, MD.

Read More

“Our Next National Health Disaster.” Boosting Research into Long COVID and Chronic Fatigue Syndrome

“Our Next National Health Disaster.” Boosting Research into Long COVID and Chronic Fatigue Syndrome

The Open Medicine Foundation supports research into Long COVID, ME/CFS, and other complex, chronic conditions, but research dollars are few and the fallout of these conditions is devastating.

Read More